Lv7
4990 积分 2022-09-16 加入
P3.13.34 Tarlatamab Efficacy and Safety in Chinese Patients with Advanced Small Cell Lung Cancer: Phase 2 DeLLphi-307
1个月前
已关闭
Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
1个月前
已完结
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
1个月前
已完结
Brief Report: Ivonescimab Combined With Etoposide Plus Carboplatin as First-Line Treatment for Extensive-Stage SCLC: Results of a Phase 1b Clinical Trial
1个月前
已完结
Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy
1个月前
已完结
Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity
1个月前
已完结
Clinical outcomes and neuroendocrine features of transformed versus primary small-cell lung cancer
1个月前
已完结
Mitochondrial transfer from glia to neurons protects against peripheral neuropathy
1个月前
已完结
Innate immune and metabolic signals induce mitochondria-dependent membrane lysis via mitoxyperiosis
2个月前
已完结
皖公网安备34019202002308
